Canopy Growth Corporation stock page - price, fundamentals, dividends - iOCharts

Ticker
CGC

Price
5.92
Stock movement up
+0.55 (10.24%)
Company name
Canopy Growth Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
2.33B
Ent value
3.82B
Price/Sales
4.09
Price/Book
0.55
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-74.16%
3 year return
-49.29%
5 year return
-
10 year return
-
Last updated: 2022-05-13

DIVIDENDS

CGC does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.09
Price to Book0.55
EV to Sales6.68

FINANCIALS

Per share

Loading...
Per share data
Current share count394.17M
EPS (TTM)-1.10
FCF per share (TTM)-1.06

Income statement

Loading...
Income statement data
Revenue (TTM)571.05M
Gross profit (TTM)-9.96M
Operating income (TTM)-786.23M
Net income (TTM)-434.11M
EPS (TTM)-1.10
EPS (1y forward)-0.64

Margins

Loading...
Margins data
Gross margin (TTM)-1.74%
Operating margin (TTM)-137.68%
Profit margin (TTM)-76.02%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash615.15M
Net receivables100.90M
Total current assets1.99B
Goodwill1.99B
Intangible assets338.75M
Property, plant and equipment0.00
Total assets6.31B
Accounts payable67.84M
Short/Current long term debt1.51B
Total current liabilities239.25M
Total liabilities2.10B
Shareholder's equity4.21B
Net tangible assets1.81B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-349.99M
Capital expenditures (TTM)67.35M
Free cash flow (TTM)-417.34M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-10.31%
Return on Assets-6.88%
Return on Invested Capital-7.59%
Cash Return on Invested Capital-7.29%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open5.50
Daily high5.95
Daily low5.46
Daily Volume7.31M
All-time high56.89
1y analyst estimate10.67
Beta1.95
EPS (TTM)-1.10
Dividend per share-
Ex-div date-
Next earnings date27 May 2022

Downside potential

Loading...
Downside potential data
CGCS&P500
Current price drop from All-time high-89.59%-15.91%
Highest price drop-91.25%-56.47%
Date of highest drop11 May 20229 Mar 2009
Avg drop from high-42.70%-11.33%
Avg time to new high37 days12 days
Max time to new high902 days1805 days
COMPANY DETAILS
CGC (Canopy Growth Corporation) company logo
Marketcap
2.33B
Marketcap category
Mid-cap
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Employees
3259
SEC filings
CEO
David Klein
Country
USA
City
Smiths Falls
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2022 ended March 31, 2022, before finan...
May 13, 2022
Canadian marijuana stocks are still struggling to find momentum, with U.S. legislation in flux. So are any Canadian marijuana stocks buys now?
May 12, 2022
Canopy Growth has said it had established new senior roles to be held by former higher-ups at Constellation Brands. Is CGC stock a buy now?
May 11, 2022
Most Canadian marijuana companies have struggled to turn a profit despite more than three years of cannabis legalization due to fewer-than-expected retail stores, cheaper rates on the black market and...
April 26, 2022
Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced that the Company is und...
April 26, 2022
U.S. Cannabis Council President & CEO Steve Hawkins joins Yahoo Finance Live to talk about cannabis legalization and sales in New Jersey, promises on marijuana regulation made by politicians, and the ...
April 21, 2022
Yahoo Finance's Brian Cheung discusses how cannabis stocks are performing.
April 20, 2022
Excitement stemming from possible U.S. pot reform has dissipated and Canopy Growth (CGC) stock is again moving lower. While better positioned to capitalize on pot reform than peers, other issues will ...
April 19, 2022
Canopy Growth Corporation (NASDAQ:CGC) has been a terrible investment in the past two years. CGC stock lost more than 80% of its market capitalization since its peak of $42.93 per share in February 20...
April 18, 2022
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
April 9, 2022
Next page